| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 80 | 2023 | 1171 | 9.560 |
Why?
|
| Shock, Cardiogenic | 32 | 2023 | 228 | 6.540 |
Why?
|
| Aortic Valve Stenosis | 29 | 2023 | 476 | 5.660 |
Why?
|
| Transcatheter Aortic Valve Replacement | 20 | 2023 | 314 | 5.360 |
Why?
|
| Heart Valve Prosthesis Implantation | 23 | 2023 | 563 | 4.700 |
Why?
|
| Extracorporeal Membrane Oxygenation | 26 | 2023 | 581 | 4.680 |
Why?
|
| Heart Failure | 55 | 2023 | 2516 | 4.400 |
Why?
|
| Aortic Valve | 27 | 2023 | 581 | 3.200 |
Why?
|
| Heart Valve Prosthesis | 16 | 2022 | 386 | 3.040 |
Why?
|
| Cardiac Catheterization | 18 | 2022 | 687 | 2.920 |
Why?
|
| Hemodynamics | 23 | 2023 | 935 | 2.640 |
Why?
|
| Heart Transplantation | 25 | 2022 | 908 | 2.220 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2021 | 180 | 2.100 |
Why?
|
| Bioprosthesis | 5 | 2022 | 167 | 2.060 |
Why?
|
| Ventricular Function, Left | 15 | 2022 | 603 | 1.860 |
Why?
|
| Mitral Valve | 3 | 2021 | 271 | 1.590 |
Why?
|
| Prosthesis Design | 21 | 2022 | 749 | 1.510 |
Why?
|
| Percutaneous Coronary Intervention | 5 | 2019 | 342 | 1.500 |
Why?
|
| Treatment Outcome | 88 | 2023 | 32848 | 1.460 |
Why?
|
| Angioplasty, Balloon, Coronary | 15 | 2012 | 314 | 1.430 |
Why?
|
| Heart Ventricles | 11 | 2023 | 846 | 1.310 |
Why?
|
| Prosthesis Failure | 5 | 2017 | 206 | 1.280 |
Why?
|
| Aortic Valve Insufficiency | 6 | 2020 | 167 | 1.240 |
Why?
|
| Prosthesis Implantation | 8 | 2022 | 263 | 1.240 |
Why?
|
| Cardiomyopathies | 11 | 2017 | 610 | 1.230 |
Why?
|
| Thrombosis | 9 | 2022 | 781 | 1.200 |
Why?
|
| Myocarditis | 5 | 2019 | 190 | 1.150 |
Why?
|
| Endovascular Procedures | 4 | 2021 | 516 | 1.120 |
Why?
|
| Heart Arrest | 4 | 2023 | 358 | 1.040 |
Why?
|
| Mitral Valve Stenosis | 2 | 2017 | 50 | 1.040 |
Why?
|
| Humans | 192 | 2024 | 261506 | 1.000 |
Why?
|
| Saphenous Vein | 10 | 2017 | 95 | 0.990 |
Why?
|
| Echocardiography, Transesophageal | 11 | 2021 | 303 | 0.970 |
Why?
|
| Myocardium | 4 | 2020 | 1313 | 0.960 |
Why?
|
| Coronary Stenosis | 4 | 2018 | 117 | 0.950 |
Why?
|
| Myocardial Infarction | 13 | 2018 | 1374 | 0.950 |
Why?
|
| Intra-Aortic Balloon Pumping | 7 | 2012 | 69 | 0.910 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2021 | 126 | 0.880 |
Why?
|
| Stents | 13 | 2017 | 1096 | 0.850 |
Why?
|
| Pulmonary Embolism | 3 | 2022 | 329 | 0.840 |
Why?
|
| Male | 114 | 2023 | 123000 | 0.840 |
Why?
|
| Respiratory Insufficiency | 5 | 2021 | 330 | 0.830 |
Why?
|
| Anterior Wall Myocardial Infarction | 2 | 2012 | 13 | 0.810 |
Why?
|
| Tricuspid Valve | 2 | 2022 | 68 | 0.800 |
Why?
|
| Septal Occluder Device | 4 | 2014 | 49 | 0.770 |
Why?
|
| Lung Transplantation | 2 | 2023 | 359 | 0.760 |
Why?
|
| Coronary Artery Bypass | 10 | 2017 | 708 | 0.750 |
Why?
|
| Thrombectomy | 1 | 2021 | 158 | 0.740 |
Why?
|
| Heart, Artificial | 2 | 2020 | 77 | 0.740 |
Why?
|
| Heart Atria | 3 | 2023 | 352 | 0.720 |
Why?
|
| Retrospective Studies | 48 | 2023 | 37905 | 0.720 |
Why?
|
| Ventricular Dysfunction, Left | 8 | 2015 | 435 | 0.720 |
Why?
|
| Drug-Eluting Stents | 9 | 2017 | 131 | 0.720 |
Why?
|
| Echocardiography | 10 | 2020 | 1182 | 0.700 |
Why?
|
| Middle Aged | 81 | 2023 | 86204 | 0.700 |
Why?
|
| Ventricular Function | 1 | 2020 | 93 | 0.680 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2022 | 261 | 0.670 |
Why?
|
| Adult | 58 | 2023 | 77950 | 0.650 |
Why?
|
| Patient Care Team | 3 | 2020 | 795 | 0.640 |
Why?
|
| Ventricular Septal Rupture | 3 | 2013 | 6 | 0.620 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2017 | 3 | 0.620 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 164 | 0.620 |
Why?
|
| Risk Factors | 30 | 2023 | 17523 | 0.590 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2014 | 318 | 0.580 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2017 | 67 | 0.580 |
Why?
|
| Coronary Artery Disease | 8 | 2024 | 1011 | 0.580 |
Why?
|
| Carcinoid Heart Disease | 1 | 2016 | 12 | 0.570 |
Why?
|
| Aged | 60 | 2021 | 70117 | 0.560 |
Why?
|
| Hemorrhage | 5 | 2020 | 712 | 0.560 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2016 | 44 | 0.560 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2016 | 13 | 0.560 |
Why?
|
| Heart Aneurysm | 2 | 2017 | 42 | 0.560 |
Why?
|
| Compassionate Use Trials | 4 | 2017 | 21 | 0.560 |
Why?
|
| Recovery of Function | 6 | 2021 | 703 | 0.550 |
Why?
|
| Coronary Angiography | 11 | 2024 | 598 | 0.550 |
Why?
|
| Female | 81 | 2023 | 141928 | 0.540 |
Why?
|
| Severity of Illness Index | 12 | 2021 | 4320 | 0.540 |
Why?
|
| Stroke Volume | 9 | 2022 | 577 | 0.540 |
Why?
|
| Graft Occlusion, Vascular | 6 | 2017 | 118 | 0.540 |
Why?
|
| Equipment Failure | 5 | 2014 | 191 | 0.530 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 87 | 0.520 |
Why?
|
| Eosinophils | 1 | 2016 | 162 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.500 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2016 | 105 | 0.500 |
Why?
|
| Heart Diseases | 1 | 2020 | 732 | 0.470 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2013 | 22 | 0.470 |
Why?
|
| Cardiac Surgical Procedures | 7 | 2023 | 1237 | 0.470 |
Why?
|
| Coronary Circulation | 3 | 2018 | 253 | 0.470 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2017 | 422 | 0.470 |
Why?
|
| Vascular Fistula | 3 | 2015 | 41 | 0.460 |
Why?
|
| Ventricular Function, Right | 2 | 2013 | 111 | 0.450 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 739 | 0.450 |
Why?
|
| Balloon Valvuloplasty | 1 | 2013 | 31 | 0.440 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 74 | 0.440 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 170 | 0.430 |
Why?
|
| Hospital Mortality | 9 | 2023 | 1274 | 0.430 |
Why?
|
| Foreign Bodies | 1 | 2014 | 145 | 0.420 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.420 |
Why?
|
| Puerperal Disorders | 1 | 2012 | 41 | 0.410 |
Why?
|
| Endocarditis | 1 | 2013 | 125 | 0.410 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.410 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 551 | 0.410 |
Why?
|
| Postoperative Complications | 14 | 2023 | 5542 | 0.400 |
Why?
|
| Lung | 2 | 2020 | 3151 | 0.390 |
Why?
|
| Stellate Ganglion | 1 | 2011 | 15 | 0.390 |
Why?
|
| Autonomic Nerve Block | 1 | 2011 | 12 | 0.390 |
Why?
|
| Time Factors | 18 | 2018 | 12926 | 0.390 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 99 | 0.380 |
Why?
|
| Aneurysm, False | 1 | 2012 | 153 | 0.360 |
Why?
|
| Clinical Competence | 1 | 2018 | 1270 | 0.360 |
Why?
|
| Computer Simulation | 2 | 2005 | 1529 | 0.350 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2022 | 473 | 0.350 |
Why?
|
| Coronary Restenosis | 4 | 2011 | 63 | 0.350 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 313 | 0.350 |
Why?
|
| Heart Defects, Congenital | 2 | 2021 | 1697 | 0.350 |
Why?
|
| Thoracotomy | 4 | 2022 | 220 | 0.340 |
Why?
|
| Respiration, Artificial | 4 | 2021 | 577 | 0.340 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2014 | 133 | 0.340 |
Why?
|
| Sarcoidosis | 3 | 2017 | 112 | 0.330 |
Why?
|
| Equipment Design | 10 | 2017 | 1204 | 0.330 |
Why?
|
| Prosthesis-Related Infections | 2 | 2019 | 232 | 0.330 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 134 | 0.320 |
Why?
|
| Heart-Lung Transplantation | 1 | 2008 | 24 | 0.320 |
Why?
|
| Chronic Disease | 5 | 2023 | 1819 | 0.320 |
Why?
|
| Survivors | 1 | 2014 | 1031 | 0.320 |
Why?
|
| Risk Assessment | 13 | 2022 | 6869 | 0.320 |
Why?
|
| Tracheostomy | 2 | 2021 | 243 | 0.320 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2008 | 57 | 0.320 |
Why?
|
| Emergency Treatment | 2 | 2008 | 105 | 0.320 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2021 | 500 | 0.310 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 655 | 0.310 |
Why?
|
| Follow-Up Studies | 20 | 2022 | 14889 | 0.310 |
Why?
|
| Metals | 5 | 2017 | 155 | 0.300 |
Why?
|
| Gastrectomy | 3 | 2022 | 451 | 0.300 |
Why?
|
| Stomach Volvulus | 1 | 2007 | 4 | 0.300 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2007 | 13 | 0.300 |
Why?
|
| Acute Coronary Syndrome | 4 | 2014 | 259 | 0.300 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2022 | 62 | 0.290 |
Why?
|
| Heart Injuries | 2 | 2019 | 40 | 0.290 |
Why?
|
| Sternum | 2 | 2022 | 100 | 0.290 |
Why?
|
| Pulmonary Veins | 3 | 2021 | 174 | 0.290 |
Why?
|
| Electrocardiography | 7 | 2017 | 1145 | 0.280 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 81 | 0.280 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 475 | 0.280 |
Why?
|
| Cause of Death | 3 | 2020 | 752 | 0.280 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2007 | 125 | 0.280 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 224 | 0.280 |
Why?
|
| Hypertension, Pulmonary | 2 | 2009 | 462 | 0.280 |
Why?
|
| Peptide Fragments | 3 | 2020 | 1271 | 0.280 |
Why?
|
| Hirudins | 3 | 2020 | 65 | 0.270 |
Why?
|
| Pulmonary Alveoli | 1 | 2007 | 208 | 0.270 |
Why?
|
| Sternotomy | 2 | 2022 | 58 | 0.270 |
Why?
|
| Calcium | 2 | 2022 | 1537 | 0.270 |
Why?
|
| Anticoagulants | 4 | 2020 | 787 | 0.260 |
Why?
|
| Thrombolytic Therapy | 2 | 2022 | 257 | 0.260 |
Why?
|
| Thromboembolism | 2 | 2011 | 155 | 0.260 |
Why?
|
| Blood Transfusion | 4 | 2017 | 583 | 0.250 |
Why?
|
| Antithrombins | 2 | 2020 | 74 | 0.240 |
Why?
|
| Blood Loss, Surgical | 2 | 2017 | 309 | 0.240 |
Why?
|
| Aged, 80 and over | 19 | 2022 | 29902 | 0.240 |
Why?
|
| Coronary Vessels | 3 | 2017 | 665 | 0.240 |
Why?
|
| Incidental Findings | 2 | 2020 | 272 | 0.230 |
Why?
|
| Biomarkers | 4 | 2015 | 5047 | 0.230 |
Why?
|
| Extracorporeal Circulation | 1 | 2023 | 43 | 0.230 |
Why?
|
| Intraoperative Complications | 2 | 2017 | 301 | 0.230 |
Why?
|
| Blood Coagulation Disorders | 2 | 2014 | 120 | 0.220 |
Why?
|
| Peroneal Neuropathies | 1 | 2022 | 1 | 0.220 |
Why?
|
| Intestinal Fistula | 1 | 2002 | 44 | 0.220 |
Why?
|
| Sirolimus | 1 | 2007 | 814 | 0.220 |
Why?
|
| Fibrinolytic Agents | 1 | 2005 | 324 | 0.210 |
Why?
|
| Myocardial Contraction | 1 | 2023 | 291 | 0.210 |
Why?
|
| Embolic Protection Devices | 1 | 2021 | 5 | 0.210 |
Why?
|
| Pulmonary Circulation | 2 | 2021 | 131 | 0.210 |
Why?
|
| Device Removal | 5 | 2021 | 337 | 0.200 |
Why?
|
| Coronary Disease | 1 | 2006 | 764 | 0.200 |
Why?
|
| Paclitaxel | 5 | 2011 | 1996 | 0.200 |
Why?
|
| Atrial Fibrillation | 4 | 2016 | 719 | 0.200 |
Why?
|
| Biopsy | 6 | 2019 | 3443 | 0.200 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2015 | 226 | 0.200 |
Why?
|
| Heart Conduction System | 2 | 2016 | 165 | 0.200 |
Why?
|
| Cardiovascular System | 1 | 2022 | 145 | 0.190 |
Why?
|
| Air Ambulances | 1 | 2020 | 28 | 0.190 |
Why?
|
| Gastric Bypass | 1 | 2021 | 81 | 0.190 |
Why?
|
| United States | 15 | 2023 | 15433 | 0.190 |
Why?
|
| Catheter Obstruction | 1 | 2020 | 8 | 0.190 |
Why?
|
| Texas | 7 | 2022 | 6311 | 0.190 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 1375 | 0.190 |
Why?
|
| Transportation of Patients | 1 | 2020 | 59 | 0.190 |
Why?
|
| Benchmarking | 1 | 2022 | 273 | 0.180 |
Why?
|
| Reoperation | 5 | 2020 | 1382 | 0.180 |
Why?
|
| Aortic Diseases | 1 | 2002 | 206 | 0.180 |
Why?
|
| Brachiocephalic Trunk | 1 | 2020 | 43 | 0.180 |
Why?
|
| Vaping | 1 | 2020 | 33 | 0.180 |
Why?
|
| Multiple Organ Failure | 3 | 2006 | 177 | 0.180 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 192 | 0.180 |
Why?
|
| Endarterectomy, Carotid | 1 | 2020 | 121 | 0.180 |
Why?
|
| Comorbidity | 3 | 2020 | 2352 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2012 | 244 | 0.170 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 92 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 7551 | 0.170 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 176 | 0.170 |
Why?
|
| Femoral Artery | 1 | 2020 | 210 | 0.170 |
Why?
|
| Cardiologists | 1 | 2019 | 33 | 0.170 |
Why?
|
| Postpartum Period | 1 | 2020 | 259 | 0.170 |
Why?
|
| Surgical Wound Infection | 1 | 2002 | 450 | 0.170 |
Why?
|
| Clinical Protocols | 2 | 2018 | 467 | 0.170 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2002 | 384 | 0.160 |
Why?
|
| Bilirubin | 1 | 2019 | 221 | 0.160 |
Why?
|
| Delirium | 1 | 2021 | 207 | 0.160 |
Why?
|
| Aortography | 2 | 2017 | 181 | 0.160 |
Why?
|
| Professional Practice | 1 | 2018 | 82 | 0.160 |
Why?
|
| Survival Rate | 8 | 2021 | 12221 | 0.160 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2017 | 11 | 0.160 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 29 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 314 | 0.150 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 140 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8865 | 0.150 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 66 | 0.150 |
Why?
|
| Oncologists | 1 | 2019 | 134 | 0.150 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2011 | 340 | 0.150 |
Why?
|
| Blood Component Removal | 1 | 2017 | 121 | 0.150 |
Why?
|
| Tranexamic Acid | 1 | 2017 | 47 | 0.150 |
Why?
|
| Arteries | 1 | 2018 | 274 | 0.140 |
Why?
|
| Length of Stay | 5 | 2021 | 1900 | 0.140 |
Why?
|
| Health Status | 1 | 2020 | 590 | 0.140 |
Why?
|
| Atrial Pressure | 1 | 2016 | 6 | 0.140 |
Why?
|
| Antifibrinolytic Agents | 1 | 2017 | 68 | 0.140 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2016 | 6 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 160 | 0.140 |
Why?
|
| Catheter Ablation | 2 | 2016 | 620 | 0.140 |
Why?
|
| Syncope | 1 | 2016 | 64 | 0.140 |
Why?
|
| Prognosis | 5 | 2023 | 21713 | 0.140 |
Why?
|
| Donor Selection | 1 | 2017 | 110 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2017 | 259 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2018 | 2594 | 0.140 |
Why?
|
| Tachycardia, Ventricular | 2 | 2017 | 239 | 0.140 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2016 | 44 | 0.140 |
Why?
|
| Atrial Appendage | 1 | 2016 | 55 | 0.140 |
Why?
|
| Intensive Care Units | 5 | 2023 | 717 | 0.140 |
Why?
|
| Legionella pneumophila | 1 | 2015 | 11 | 0.140 |
Why?
|
| Legionnaires' Disease | 1 | 2015 | 13 | 0.140 |
Why?
|
| Procainamide | 1 | 2015 | 13 | 0.130 |
Why?
|
| Angina Pectoris | 1 | 2015 | 80 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2013 | 1529 | 0.130 |
Why?
|
| Pneumonia | 1 | 2021 | 751 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 846 | 0.130 |
Why?
|
| Heart | 2 | 2020 | 1223 | 0.130 |
Why?
|
| Shock | 1 | 2016 | 88 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2016 | 2292 | 0.120 |
Why?
|
| Angina, Unstable | 1 | 2014 | 70 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 622 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 234 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2008 | 343 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 2016 | 214 | 0.120 |
Why?
|
| Stroke | 3 | 2020 | 1144 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2023 | 9244 | 0.120 |
Why?
|
| Heart Rupture | 1 | 2013 | 5 | 0.120 |
Why?
|
| Positron-Emission Tomography | 2 | 2024 | 2173 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2024 | 12873 | 0.120 |
Why?
|
| Pregnancy | 2 | 2020 | 7573 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 170 | 0.120 |
Why?
|
| Hospitals, Veterans | 2 | 2013 | 397 | 0.120 |
Why?
|
| Neoplasms | 4 | 2020 | 15193 | 0.110 |
Why?
|
| Catheterization | 2 | 2022 | 410 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2016 | 221 | 0.110 |
Why?
|
| Hypoxia | 1 | 2016 | 443 | 0.110 |
Why?
|
| Critical Illness | 3 | 2023 | 714 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2014 | 100 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2020 | 925 | 0.110 |
Why?
|
| Algorithms | 3 | 2020 | 3890 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2017 | 769 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 2016 | 406 | 0.110 |
Why?
|
| Acute Disease | 3 | 2011 | 2422 | 0.110 |
Why?
|
| Cardiovascular Agents | 2 | 2011 | 128 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 544 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2009 | 1467 | 0.110 |
Why?
|
| Vascular Grafting | 1 | 2012 | 50 | 0.100 |
Why?
|
| Peripartum Period | 1 | 2012 | 35 | 0.100 |
Why?
|
| Incidence | 5 | 2021 | 5673 | 0.100 |
Why?
|
| Femoral Vein | 1 | 2012 | 66 | 0.100 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2012 | 31 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 2927 | 0.100 |
Why?
|
| Neointima | 1 | 2011 | 53 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2011 | 50 | 0.100 |
Why?
|
| Central Venous Pressure | 1 | 2011 | 28 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2015 | 300 | 0.100 |
Why?
|
| Program Development | 1 | 2012 | 261 | 0.100 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2014 | 252 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 2 | 2021 | 113 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 321 | 0.100 |
Why?
|
| Arteriovenous Malformations | 1 | 2011 | 70 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Adolescent | 10 | 2017 | 31252 | 0.100 |
Why?
|
| Blood Volume | 1 | 2011 | 100 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 183 | 0.090 |
Why?
|
| Embolism | 1 | 2010 | 59 | 0.090 |
Why?
|
| Veterans | 1 | 2021 | 1641 | 0.090 |
Why?
|
| Anthracyclines | 1 | 2012 | 331 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 202 | 0.090 |
Why?
|
| Fatal Outcome | 3 | 2020 | 829 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2011 | 182 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 2218 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 546 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2011 | 587 | 0.090 |
Why?
|
| Hypotension | 1 | 2011 | 210 | 0.080 |
Why?
|
| Noonan Syndrome | 1 | 2009 | 26 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 960 | 0.080 |
Why?
|
| Diastole | 2 | 2009 | 187 | 0.080 |
Why?
|
| Chest Tubes | 1 | 2009 | 101 | 0.080 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2011 | 406 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2016 | 7702 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 755 | 0.080 |
Why?
|
| Single-Blind Method | 4 | 2011 | 409 | 0.080 |
Why?
|
| Cardiac Output, High | 1 | 2007 | 4 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 4744 | 0.080 |
Why?
|
| Infusions, Intravenous | 3 | 2005 | 1382 | 0.080 |
Why?
|
| Patient Selection | 2 | 2013 | 2055 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 4892 | 0.080 |
Why?
|
| Registries | 3 | 2023 | 2170 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 852 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2009 | 201 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2022 | 661 | 0.070 |
Why?
|
| Intracranial Embolism | 1 | 2007 | 39 | 0.070 |
Why?
|
| Obesity | 1 | 2019 | 2884 | 0.070 |
Why?
|
| Embolism, Air | 1 | 2007 | 33 | 0.070 |
Why?
|
| Arteriovenous Fistula | 1 | 2007 | 92 | 0.070 |
Why?
|
| Recurrence | 4 | 2018 | 4758 | 0.070 |
Why?
|
| Drainage | 1 | 2009 | 416 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2006 | 38 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2015 | 1225 | 0.070 |
Why?
|
| Takayasu Arteritis | 1 | 2006 | 21 | 0.070 |
Why?
|
| Quality of Life | 3 | 2023 | 4532 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 374 | 0.070 |
Why?
|
| Natriuretic Peptides | 1 | 2005 | 11 | 0.070 |
Why?
|
| Laparotomy | 1 | 2007 | 211 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 253 | 0.070 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 131 | 0.070 |
Why?
|
| Vagus Nerve | 1 | 2005 | 63 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 2138 | 0.060 |
Why?
|
| Milrinone | 1 | 2005 | 33 | 0.060 |
Why?
|
| Vasodilation | 1 | 2006 | 205 | 0.060 |
Why?
|
| Dextrans | 1 | 2005 | 90 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2006 | 142 | 0.060 |
Why?
|
| Sheep | 1 | 2005 | 258 | 0.060 |
Why?
|
| Rubidium Radioisotopes | 1 | 2024 | 6 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 787 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2004 | 24 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 354 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2005 | 232 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2011 | 806 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2576 | 0.060 |
Why?
|
| Furans | 1 | 2004 | 104 | 0.060 |
Why?
|
| Transposition of Great Vessels | 1 | 2005 | 124 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 163 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 560 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 151 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2008 | 705 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 177 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 445 | 0.060 |
Why?
|
| Eikenella corrodens | 1 | 2002 | 5 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 3 | 2012 | 429 | 0.060 |
Why?
|
| Fusobacterium Infections | 1 | 2002 | 28 | 0.060 |
Why?
|
| Hemolysis | 1 | 2022 | 127 | 0.050 |
Why?
|
| Hypertension | 2 | 2009 | 1503 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 614 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2017 | 605 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 161 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 2006 | 945 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 435 | 0.050 |
Why?
|
| Global Health | 2 | 2017 | 657 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 403 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 444 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 151 | 0.050 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 280 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2020 | 185 | 0.040 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 63 | 0.040 |
Why?
|
| Disease Progression | 3 | 2022 | 6682 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 2315 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2020 | 270 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 485 | 0.040 |
Why?
|
| Cardiac Output | 2 | 2011 | 194 | 0.040 |
Why?
|
| Heparin | 1 | 2020 | 360 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2009 | 1375 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 2195 | 0.040 |
Why?
|
| Dialysis | 1 | 2017 | 23 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 299 | 0.040 |
Why?
|
| Hematocrit | 1 | 2017 | 142 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2019 | 2203 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 471 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2023 | 899 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 120 | 0.040 |
Why?
|
| Young Adult | 5 | 2016 | 21445 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 699 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2017 | 218 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2004 | 3005 | 0.040 |
Why?
|
| Hepatomegaly | 1 | 2016 | 69 | 0.040 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 18 | 0.040 |
Why?
|
| Subclavian Artery | 2 | 2007 | 80 | 0.040 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 329 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 6009 | 0.030 |
Why?
|
| Medical Records | 1 | 2017 | 415 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 119 | 0.030 |
Why?
|
| Ascites | 1 | 2016 | 198 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 477 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 7222 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2018 | 492 | 0.030 |
Why?
|
| Critical Care | 1 | 2020 | 770 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 672 | 0.030 |
Why?
|
| Edema | 1 | 2016 | 267 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 87 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 3260 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 793 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 343 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 671 | 0.030 |
Why?
|
| Efficiency | 1 | 2014 | 99 | 0.030 |
Why?
|
| Diet | 1 | 2022 | 1440 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6207 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2014 | 155 | 0.030 |
Why?
|
| Thrombelastography | 1 | 2014 | 79 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 51 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 183 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 980 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2023 | 6100 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 509 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2014 | 286 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2016 | 834 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 3719 | 0.030 |
Why?
|
| Phlebography | 1 | 2012 | 76 | 0.030 |
Why?
|
| Palliative Care | 1 | 2023 | 2037 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2015 | 474 | 0.030 |
Why?
|
| Angiography | 1 | 2013 | 360 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 1581 | 0.020 |
Why?
|
| Patients | 1 | 2013 | 245 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 600 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 925 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4314 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 46 | 0.020 |
Why?
|
| Animals | 5 | 2011 | 59536 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 1904 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2016 | 833 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 310 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 251 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 557 | 0.020 |
Why?
|
| Plasma | 1 | 2011 | 158 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2011 | 161 | 0.020 |
Why?
|
| Greece | 1 | 2009 | 22 | 0.020 |
Why?
|
| Research Design | 1 | 2017 | 1544 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 602 | 0.020 |
Why?
|
| Endarterectomy | 1 | 2009 | 25 | 0.020 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2009 | 17 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 212 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 4988 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 2843 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14289 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 196 | 0.020 |
Why?
|
| Empyema, Pleural | 1 | 2009 | 48 | 0.020 |
Why?
|
| Contraindications | 1 | 2009 | 150 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2009 | 109 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2009 | 95 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 9180 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 649 | 0.020 |
Why?
|
| Vascular Neoplasms | 1 | 2009 | 114 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1323 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 223 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2007 | 107 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2083 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Paresis | 1 | 2007 | 54 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 183 | 0.020 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2007 | 54 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2007 | 169 | 0.020 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2005 | 14 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 737 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2008 | 319 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2005 | 170 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 3569 | 0.020 |
Why?
|
| Rheology | 1 | 2005 | 55 | 0.020 |
Why?
|
| Retreatment | 1 | 2006 | 452 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 230 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 305 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2006 | 216 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 499 | 0.020 |
Why?
|
| Cardiac Care Facilities | 1 | 2004 | 11 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2010 | 1335 | 0.020 |
Why?
|
| Device Approval | 1 | 2004 | 21 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2008 | 739 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2004 | 64 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 133 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 7548 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 462 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 1155 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 215 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 3441 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2004 | 200 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 1429 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 503 | 0.010 |
Why?
|
| Dyspnea | 1 | 2005 | 416 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 483 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 423 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 3472 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6295 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 4971 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 4938 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 2146 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 10001 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 2961 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 15862 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 34495 | 0.000 |
Why?
|